tm
Seeing Is Believing
tm
Seeing Is Believing
Fusion Pharmaceuticals's activity chart (see below) currently has 32 price targets and 28 ratings on display.
Analysts average stock forecasts to be materialized ratio is 65.63% with an average time for these price targets to be met of 253.13 days.
Most recent stock forecast was given by from TRUIST on 20-Mar-2024. First documented stock forecast 21-Jul-2020.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 04-Mar-2024
$16
$-5.55 (-25.75%)
$16
2 years 7 months 13 days ago
(20-Mar-2024)
1/2 (50%)
$-5.09 (-24.13%)
15
Buy Since 01-Dec-2022
$13
$-8.55 (-39.68%)
$13
2 years 7 months 13 days ago
(20-Mar-2024)
3/4 (75%)
$-8.09 (-38.36%)
287
Buy Since 16-Sep-2022
$11
$-10.55 (-48.96%)
2 years 7 months 14 days ago
(19-Mar-2024)
1/2 (50%)
$-10.18 (-48.06%)
496
Buy Since 21-Jul-2020
$10
2 years 7 months 14 days ago
(19-Mar-2024)
5/6 (83.33%)
$6.75 (207.69%)
861
Hold Since 19-Mar-2024
$10
$-11.55 (-53.60%)
2 years 7 months 14 days ago
(19-Mar-2024)
0/1 (0%)
$-11.18 (-52.79%)
What is FUSN (Fusion Pharmaceuticals) average time for price targets to be met?
Which analyst most recently updated their price target on FUSN (Fusion Pharmaceuticals)?
Which analyst has the most public recommendations on FUSN (Fusion Pharmaceuticals)?
Which analyst is the currently most bullish on FUSN (Fusion Pharmaceuticals)?
Which analyst is the currently most reserved on FUSN (Fusion Pharmaceuticals)?
